Boston Scientific to Present New Data on Advances in Chronic Pain Care at the 2022 North American Neuromodulation Society (NANS) Meeting

MARLBOROUGH, Mass. , Jan. 7, 2022 / / -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25 th North American Neuromodulation Society (NANS) annual meeting, in Orlando, Florida , on Jan.13-15, 2022. More than 20 abstracts have been accepted, including three late-breaking presentations.

Related Keywords

Florida ,United States ,Boston ,Massachusetts ,Orlando ,Lauren Tengler ,Magdalena Anitescu ,Nilesh Kumar Patel ,Wavewriter Alpha ,Jessica Sachariason ,Mark Wallace ,Exchange Commission ,Boston Scientific Corporation ,American Neuromodulation Society ,Center Evaluation Of Novel Fast ,Ibm ,Securities Exchange ,Boston Scientific ,Scientific Corporation ,North American Neuromodulation Society ,Spinal Cord Stimulator ,Control Trial ,Two Year Outcomes ,Simultaneous Delivery ,Multiple Modalities ,Chronic Pain Patients ,Multi Center Evaluation ,Novel Fast Acting Sub Perception Based ,Chronic Pain ,Multicenter Study ,Radiofrequency Ablation Outcomes ,Digital Tools ,Improve Access ,Treatment Efficiency ,Spinal Cord Stimulation ,Dorsal Column Axons ,Wide Dynamic Range Neurons ,Interspinous Spacers ,Boston Scientific Chronic Pain ,Fast Acting Sub Perception Therapy ,Radiofrequency Ablation ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Quarterly Reports ,Body Guidelines ,Wavewriter Alpha Prime Spinal Cord Stimulator ,Indirect Decompression ,Artificial Intelligence ,Bluetooth ,Healthcare ,Magnetic Resonance Imaging ,Nervous System ,Spain ,Acute Pain ,Branches Of Biology ,Neuromodulation ,Neurotechnology ,Nociception ,Pain Management ,Spinal Stenosis ,Stimulator ,